In contrast, in pathological conditions, deletion of Pak1 is sufficient to amplify cardiac muscle hypertrophy in response to pressure overload (Liu et al., 2011), while Pak1 overexpression mitigates muscle atrophy caused by cancer cachexia (Cerquone Perpetuini et al., 2018). Here, PAK1 is linked to cancer.